Biogen Inc.

NasdaqGS:BIIB 주식 보고서

시가총액: US$25.3b

Biogen 과거 수익 실적

과거 기준 확인 4/6

Biogen의 수입은 연평균 -30.4%의 비율로 감소해 온 반면, Biotechs 산업은 수입이 연평균 19%의 비율로 증가했습니다. 매출은 연평균 9.8%의 비율로 감소해 왔습니다. Biogen의 자기자본이익률은 9.9%이고 순이익률은 16.8%입니다.

주요 정보

-30.4%

수익 성장률

-24.3%

EPS 성장률

Biotechs 산업 성장17.0%
매출 성장률-9.8%
자기자본 수익률9.9%
순이익16.8%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter

Oct 31

Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?

Oct 01
Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?

What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E

Sep 04
What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E

Biogen: Q2 Earnings, Share Price May Have Bottomed Out As CEO Makes Mark

Aug 17

Biogen Stock: Cheapish, But With Few Growth Prospects

Jul 11

Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

May 23
Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)

Apr 29

Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Apr 28
Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

The Price Is Right For Biogen Inc. (NASDAQ:BIIB)

Apr 15
The Price Is Right For Biogen Inc. (NASDAQ:BIIB)

We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings

Feb 21
We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings

Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Feb 16
Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)

Feb 14

Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly

Jan 31
Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly

Biotech And Pharma Diversification Pays Off

Jan 25

Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult

Dec 26
Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult

An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued

Oct 21
An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued

Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Oct 03
Is Biogen (NASDAQ:BIIB) Using Too Much Debt?

Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?

Jul 16
Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?

Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet

Jun 28
Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet

수익 및 비용 분석

Biogen 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NasdaqGS:BIIB 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 249,6081,6152,3162,067
30 Jun 249,6721,1592,4892,212
31 Mar 249,6631,1672,4762,333
31 Dec 239,8361,1612,5022,458
30 Sep 239,9931,4622,5322,490
30 Jun 239,9722,6652,3432,303
31 Mar 2310,1053,1312,3792,248
31 Dec 2210,1733,0472,4092,229
30 Sep 2210,3632,8652,5702,325
30 Jun 2210,6342,0592,6612,478
31 Mar 2210,8201,4502,7262,535
31 Dec 2110,9821,5562,6802,497
30 Sep 2111,1011,5462,7003,522
30 Jun 2111,6981,9182,6193,960
31 Mar 2112,6043,0122,5364,023
31 Dec 2013,4454,0012,5163,985
30 Sep 2014,2635,0822,3702,949
30 Jun 2014,4875,9272,3512,348
31 Mar 2014,4225,8792,3652,178
31 Dec 1914,3785,8892,3592,273
30 Sep 1914,2335,3962,2852,193
30 Jun 1914,0725,2942,2292,160
31 Mar 1913,8124,6672,1762,664
31 Dec 1813,4534,4312,1092,597
30 Sep 1813,2343,1872,0702,573
30 Jun 1812,8722,9682,0072,512
31 Mar 1812,5942,9641,9212,327
31 Dec 1712,2742,5391,9362,254
30 Sep 1711,8393,4861,8592,200
30 Jun 1711,7173,2931,8872,283
31 Mar 1711,5333,4801,9491,959
31 Dec 1611,4493,7031,9501,973
30 Sep 1611,4163,8852,0351,981
30 Jun 1611,2383,8182,0511,972
31 Mar 1610,9363,6952,0501,990
31 Dec 1510,7643,5472,1132,013
30 Sep 1510,5653,5992,1041,971
30 Jun 1510,2993,4902,1961,869
31 Mar 1510,1283,2772,2811,825
31 Dec 149,7032,9352,2321,893
30 Sep 149,0282,5092,1541,816
30 Jun 148,3452,1391,9901,808
31 Mar 147,6471,9161,8441,689
31 Dec 136,9321,8621,7121,444

양질의 수익: BIIB 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: BIIB 의 현재 순이익 이익률 (16.8%) 작년보다 높습니다 (14.6%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: BIIB 의 수입은 지난 5년 동안 매년 30.4% 씩 감소했습니다.

성장 가속화: 지난 1년간 BIIB 의 수익 증가율( 10.5% )은 연간 평균( -30.4% 초과합니다. ).

수익 대 산업: 지난 1년간 BIIB 수익 증가율( 10.5% )은 Biotechs 업계 -2.3% 초과했습니다.

자기자본 수익률

높은 ROE: BIIB 의 자본 수익률( 9.9% )은 낮음으로 간주됩니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y